TGFRX Mutual Fund

TGFRX Mutual Fund

NAV$53.23
See how much of TGFRX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Aug 31, 2026

Net Assets
$30M
Expense Ratio
1.95%
Dividend Yield (Current)
-
Holdings
27
Inception Date
Dec 30, 1998
Fund Family
Tanaka Capital Management
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO

Performance

YTD-5.39%
1 Year-7.35%
3 Year+24.71%
5 Year+10.13%
10 Year+14.16%

Asset Allocation

Stocks: 100.00%
See how much of TGFRX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report comes with FundXLS. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
CORTCorcept Therapeutics Inc15.08%
NUVBNuvation Bio Inc8.22%
NVDANvidia Corp7.84%
ORA:CAAura Minerals Inc6.01%
AAPLApple Inc5.29%
Top 10 Concentration: 63.67%Report Date: Aug 31, 2026
Download all 27 holdings for TGFRX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Latest Distribution
$2.65
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

TGFRX Mutual Fund Overview

TGFRX Mutual Fund (TANAKA Growth Fund Class R) is managed by Tanaka Capital Management with $29.9M in net assets. TGFRX expense ratio is 1.95%, holding 27 positions across sectors including Health Care, Information Technology, Materials. Inception date: 1998-12-30.

TGFRX performance shows a YTD return of -5.39%. The 1-year return is -7.35% and the 5-year return is 10.13%.

TGFRX top holdings include Corcept Therapeutics Inc (15.1%), Nuvation Bio Inc (8.2%), Nvidia Corp (7.8%), Aura Minerals Inc (6.0%), Apple Inc (5.3%). Go to all TGFRX holdings, TGFRX sectors, or TGFRX dividends.

TGFRX can be compared against other funds. Use TGFRX overlap to find shared positions, or TGFRX vs another fund for a side-by-side view. TGFRX alternatives are available via the screener, along with tax-loss harvesting opportunities.